Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo Díaz Rodríguez E, Sotillo R, Schvartzman JM, Benezra R. Proceedings of the National Academy of Sciences of the USA 105(43):16719-24. FI: 9.432 (Q1) Neuregulins and cancer Montero JC, Rodríguez-Barrueco R, Ocaña A, Díaz Rodríguez E, Esparís Ogando A, Pandiella A. Clinical Cancer Research 14(11):3237-41. FI: 6.747 (Q1) Identifying breast cancer druggable oncogenic alterations: lessons learned and future targeted options Ocaña A, Pandiella A. Clinical Cancer Research 14(4):961-70. FI: 6.747 (Q1) Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo Mitsiades CS, Ocio EM, Pandiella A, Maiso P, Gajate C, Garayoa M, Vilanova D, Montero JC, Mitsiades N, McMullan CJ, Munshi NC, Hideshima T, Chauhan D, Aviles P, Otero G, Faircloth G, Mateos MV, Richardson PG, Mollinedo F, San-Miguel JF, Anderson KC. Cancer Research 68(13):5216-25. FI: 7.543 (Q1) Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity Montero JC, López-Pérez R, San Miguel JF, Pandiella A. Haematologica- The Hematology Journal 93(6):851-9. FI: 6.416 (Q1) Novel tyrosine kinase inhibitors in the treatment of cancer Ocana A, Serrano R, Calero R, Pandiella A. Current Drug Targets 10(6):575-6. FI: 3.932 (Q1) Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target Montero JC, Ocaña A, Abad M, Ortíz Ruiz MJ, Pandiella A, Esparís Ogando A. PLoS One 4(5):e5565. FI: 4.351 (Q1) Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks Ocio EM, Maiso P, Chen X, Garayoa M, Álvarez Fernández S, San-Segundo L, Vilanova D, López-Corral L, Montero JC, Hernández-Iglesias T, de Alava E, Galmarini C, Avilés P, Cuevas C, San-Miguel JF, Pandiella A. Blood 113(16):3781-91. FI: 10.555 (Q1) Effect of multikinase inhibitors on caspase-independent cell death and DNA damage in HER2-overexpressing breast cancer cells Seoane S, Montero JC, Ocaña A, Pandiella A. Journal of the National Cancer Institute 102(18):1432-46. FI: 14.069 (Q1) Multisite phosphorylation of Erk5 in mitosis Díaz Rodríguez E, Pandiella A. Journal of Cell Science 123(Pt18):3146-56. FI: 6.144 (Q1)
|
